Remove Artificial Inteligence Remove CTO Remove Pharmaceuticals Remove Recruiting
article thumbnail

Chief AI officer: What it takes to land the C-suiteā€™s hottest new job

CIO

As countless organizations race to investigate or adopt artificial intelligence technologies, many are building out an AI skilled workforce. That includes the decision to appoint or hire a chief artificial intelligence officer (CAIO). Ozzie Coto, chief AI officer and CTO at The Cult Branding Co.,

CTO 307
article thumbnail

CIOs take aim at Silicon Valley talent

CIO

That sense of purpose and yearning to do meaningful work is the ace in the hole for Optum Enterprise CTO Francois Charette, who has hired a number of Silicon Valley technologists in recent months. P&G is applying AI at scale and automating the machine learning deployment process, he says.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vinehealth, offering digital support for cancer patients and SaaS for R&D, gets $5.5M to launch in the US

TechCrunch

The round, which co-founder and CTO Georgina Kirby describes as a “late seed” — ahead of a planned Series A “in the next 12-18 months” — is led by Talis Capital with participation from previous investors Playfair Capital and Ascension. million seed round as it prepares to expand into the U.S.

article thumbnail

NeuraLight emerges from stealth with $5.5M to digitize neurological evaluation and care

TechCrunch

Breakstone now leads NeuraLight as the company’s CEO alongside co-founder and CTO Edmund Ben-Ami. Breakstone and Ben-Ami have recruited talent from the research and pharmaceutical industries, along with alumni from Google, Chorus.ai and Viz.ai.

article thumbnail

10 Ways Machine Learning and AI Revolutionizes Medicine and Pharma

Altexsoft

According to McKinsey , machine learning and artificial intelligence in pharma and medicine are going to revolutionize the industries to help them make better decisions, optimize innovations, improve the efficiency of clinical and research trials, and provide for new tools for physicians, consumers, regulators, and even insurers.